Objective-Nonclassical monocytes (NCM) function to maintain vascular homeostasis by crawling or patrolling along the vessel wall. This subset of monocytes responds to viruses, tumor cells, and other pathogens to aid in protection of the host. In this study, we wished to determine how early atherogenesis impacts NCM patrolling in the vasculature. Approach and Results-To study the role of NCM in early atherogenesis, we quantified the patrolling behaviors of NCM in ApoE −/− (apolipoprotein E) and C57BL/6J mice fed a Western diet. Using intravital imaging, we found that NCM from Western diet-fed mice display a 4-fold increase in patrolling activity within large peripheral blood vessels. Both human and mouse NCM preferentially engulfed OxLDL (oxidized low-density lipoprotein) in the vasculature, and we observed that OxLDL selectively induced NCM patrolling in vivo. Induction of patrolling during early atherogenesis required scavenger receptor CD36, as CD36 −/− mice revealed a significant reduction in patrolling activity along the femoral vasculature. Mechanistically, we found that CD36-regulated patrolling was mediated by a SFK (src family kinase) through DAP12 (DNAX activating protein of 12KDa) adaptor protein.
+ CCR2 high monocytes (CM), aid in vascular maintenance, and migrate to the sites of plaque formation during atherosclerosis. [2] [3] [4] Although other leukocytes can bind to and crawl along the endothelium, NCM seem to play the primary role of sentinels by patrolling the endothelium over long distances, often traveling against directional blood flow. A previous study by our group found that NCM are regulated by the transcription factor Nr4a1, and with the deletion of this gene, Ly6C − monocytes are absent from blood and bone marrow. 5 Nr4a1 −/− mice that were bred onto atherosclerosis-prone Ldlr −/− (low-density lipoprotein) or Apoe −/− (apolipoprotein E) mice and fed a Western diet (WD) showed a 3-fold increase in atherosclerotic plaque formation and a greater inflammatory phenotype of macrophages in atherosclerotic lesions. 6, 7 This study suggests that NCM likely play a role in the resolution of vessel inflammation during the onset of atherosclerosis. However, the effect of an atherogenic diet on vascular patrolling of NCM has not been examined in detail.
During atherogenesis, LDLs circulate in the bloodstream and eventually enter the subendothelial layer of the vessel wall, where they become trapped and oxidized to form modified forms of LDL. 8 These modified forms of LDL, such as minimally modified LDL and oxidized LDL (OxLDL), are considered immunogenic as well as atherogenic and can trigger leukocyte recruitment to the vascular wall. 9, 10 Intimal cell proliferation and Ly6C
+ monocyte recruitment to nascent lesions are markedly increased after 2 weeks of WD feeding. 11 Scavenger receptors (SRs), such as SR class A (SR-A) and CD36 (class B), recognize and bind to specific oxidized lipid moieties present on OxLDL.
12,13 SR-A seems to signal in conjunction with TLRs (Toll-like receptors), as well as with SFK (src family kinase) to mediate cell adhesion, possibly through G i/o signaling pathways. [14] [15] [16] [17] On the contrary, CD36 can use DAP12 (DNAX activating protein of 12KDa) and FcRγ adaptor proteins to further signal to spleen tyrosine kinase (Syk) and SFK. 18, 19 As part of our goal to study NCM in early atherogenesis, we asked which key intracellular proteins are involved in the induction of NCM patrolling. The role of SRs and the intracellular signaling downstream of these receptors in NCM as they relate to patrolling has not been investigated.
Using a novel method of intravital imaging of the mouse femoral vasculature during atherogenesis, we show that NCM preferentially internalize OxLDL through a SR-mediated process involving DAP12 and SFK that induces their patrolling along the endothelium.
Materials and Methods
Materials and Methods are available in the online-only Data Supplement.
Results

Increased Ly6C − NCM Patrolling Along Large Peripheral Blood Vessel Endothelium During Early Atherogenesis
We hypothesized that vascular inflammation during atherogenesis in large blood vessels would lead to changes in NCM patrolling activity. To address this, we used an established a mouse model of early atherosclerosis by feeding a high fat WD (0.2% cholesterol, 42% calories from fat) to ApoE −/− mice or C57BL/6J (B6) mice for up to 28 days. [20] [21] [22] [23] Age-and sexmatched groups of B6 or ApoE −/− mice crossed to CX 3 CR1 g fp/+ CCR2 rfp/+ reporter mice were fed a WD for either 1 or 28 days and imaged for patrolling activity of CX 3 CR1 high CCR2 low monocytes using a novel femoral artery imaging method (described in Figure I in the online-only Data Supplement). These mice enable us to visualize both NCM (CX 3 CR1 gfp/+ ) and CM (CCR2 rfp/+ ) by confocal microscopy as expression of CX 3 CR1 is higher on NCM and expression of CCR2 is higher on CM 1 . NCM from WD-fed mice showed a significant 4-fold increase in patrolling activity along the vascular endothelium in vivo compared with NCM from chow-fed mice ( Figure 1A and 1B). This increase was observed even after 1 day of WD feeding and is sustained through 4 weeks of WD feeding. When either B6 or ApoE −/− mice were placed on WD for 2 weeks and subsequently put back on chow for an equal amount of time, the NCM showed reduced patrolling activity, almost reverting to the levels of pre-WD feeding ( Figure 1A, regression) . The overall speed of monocyte patrolling was also affected by WD feeding ( Figure 1C ), as chow-fed mice exhibited the expected average of 12 μm/min (ranging from 6 to 24 μm/min), 3 but NCM from WD-fed mice had reduced patrolling speeds, down to 5 μm/min (ranging from 2 to 10 μm/min). Additional characteristics, such as track length, track displacement (distance from start point to end point of track), and confinement (displacement/length, 0=circular track, 1=straight track), were not significantly different ( Figure IIA in the online-only Data Supplement).
Earlier studies have reported that ApoE −/− mice fed a WD develop monocytosis in the Ly6C + compartment. 4, 24, 25 We wanted to confirm that the observed increase in patrolling activity was not simply because of increased numbers of NCM present in the blood during atherogenesis. We measured the frequency of Ly6C − monocytes in chow-fed mice and WD-fed mice by flow cytometry. In both B6 and ApoE −/− mice, we observed an increase in the frequency of classical Ly6C + monocytes ( Figure IIB in the online-only Data Supplement), but not Ly6C − monocytes ( Figure 1D ). Additionally, we measured monocyte proliferation using bromodeoxyuridine incorporation. We found that Ly6C + monocytes incorporated bromodeoxyuridine in 50% to 70% of cells by 48 hours in WD-fed mice compared with only 0.5% to 1% incorporation into Ly6C − monocytes ( Figure IIC in the online-only Data Supplement). Importantly, these data indicate that during early atherogenesis, the increase in patrolling of Ly6C − monocytes on blood vessel walls is because of changes in activation of NCM and not the result of increased numbers of NCM circulating in the blood.
Analysis of NCM in Early Atherogenesis Shows Increased Expression of Genes Involved in Cell Migration, Cholesterol Efflux, and Vascular Repair
To determine whether there were gene expression changes in monocyte subsets during atherogenesis that were related to functional changes in patrolling activity, we sorted CM and NCM from 8-week WD-fed mice and cohort chow-fed mice (gating strategy shown in Figure IIIA in the online-only Data Supplement) and performed RNA-seq analysis. Genes that are involved in cell migration (Rab GTPase activation, kinases, integrin activation, and lamellipodia components) [26] [27] [28] and resolution of inflammation/vascular repair were more highly expressed in Ly6C − monocytes from WD-fed mice than in Ly6C − monocytes fed chow or in Ly6C + monocytes (Figure 2A ). Based on our earlier studies using global Nr4a1 −/− mice, 6 we hypothesized that the absence of patrolling by Ly6C − monocytes would increase atherosclerotic progression. We generated mice selectively lacking Ly6C − monocytes (E2-def) with no observable changes in any other immune cell type in vivo 30 and transplanted bone marrow from either wild-type (WT) or E2-def mice into Ldlr −/− recipients. After checking for successful bone marrow reconstitution ( Figure IIIB in the online-only Data Supplement) and feeding a high cholesterol diet for 15 weeks, we assessed plaque formation by oil red O staining in WT-Ldlr −/− and E2-def-Ldlr −/− mice. We found a 2-fold increase in plaque formation in E2-deficient mice selectively lacking NCM ( Figure 2B and 2C), indicating that NCM are functionally atheroprotective.
We next examined whether NCM showed differences in free or esterified cholesterol accumulation. Blood monocytes from mice and humans (gating strategies shown in Figure IIIA and IIIC in the online-only Data Supplement, respectively) were stained with either bodipy (identifies esterified cholesterol/lipid droplets) or filipin (identifies free cholesterol). Mouse NCM had lower cholesteryl ester content ( Figure 2D ) than CM, even after 4 weeks of WD-feeding. We observed no changes in filipin staining ( Figure 2E ). Human nonclassical CD16 + monocytes also had lower cholesteryl ester content than CD14 + CM ( Figure 2F ). This correlates with our RNAseq findings of increased mRNA expression of both of the key cholesterol transporters, ABCG1 and ABCA1, in NCM isolated from WD-fed mice (Figure 2A ), suggesting that these transporters regulate the cholesterol content of NCM.
Filamentous-Actin Formation Is Increased in NCM From WD-Fed Mice
Leukocyte migration involves high-affinity conformation integrin activation, allowing the cell to bind to endothelial cell surface ligands and form lamellipodia for patrolling, which involves the polymerization and depolymerization of filamentous-actin (F-actin) in a front-to-rear wave-like pattern. Many of the genes that were specifically upregulated in Ly6C − monocytes from WD-fed mice are involved in either integrin activation or in forming cellular cytoskeletal structures necessary for cell crawling along the vasculature. Initially, we asked whether Gαi chemokine receptors were involved in inducing patrolling during atherogenesis. We measured patrolling NCM in WD-fed mice before and after pertussis toxin injections and could not find a significant decrease in patrolling frequency or any change in patrolling speeds ( Figure IVA in the online-only Data Supplement). We then measured integrin expression in both monocytes from WD-fed mice ( Figure IVB and IVC in the online-only Data Supplement) and from human subjects with documented coronary artery disease ( Figure IVD in the online-only Data Supplement), but found no significant changes.
We next measured F-actin formation in blood monocyte subsets from chow-fed or WD-fed mice by confocal microscopy using phalloidin-AF488, a phallotoxin that binds to and stabilizes F-actin. Monocytes sorted from WD-fed mice exhibited greater F-actin content than monocytes from chow-fed mice ( Figure 3A) . When F-actin intensity was quantified for each cell within each condition, the Ly6C − monocytes from WD-fed mice had increased F-actin content compared with the Ly6C + subset ( Figure 3B ). These data suggest that Ly6C − NCM more readily form the machinery necessary for cell movement within blood vessels, particularly in WD-fed mice.
Oxidized Lipoprotein Moieties Present in Early Atherogenesis Induce NCM Patrolling
Previous studies have reported that human and mouse NCM do not ingest native LDL or VLDL (very low-density Figure 4A ). Compared with CM, NCM showed 2-fold increased uptake of OxLDL ( Figure 4B ). We next looked at F-actin formation by confocal microscopy in NCM when OxLDL was added ( Figure 4C ). Again we saw a significant increase in F-actin intensity in the presence of OxLDL ( Figure 4D ), suggesting that the OxLDL can mobilize NCM to adhere to the endothelium and patrol.
To determine whether OxLDL could directly increase patrolling monocyte activity, OxLDL, native LDL, or vehicle (phosphate-buffered saline) was injected intravenously into CX 3 CR1 gfp/+ CCR2 rfp/+ ApoE −/− mice ( Figure 4E ). Patrolling monocytes were quantified pre-and post-injection by imaging an area of the femoral vasculature over time. We found that OxLDL injection significantly induced CX 3 CR1 high NCM patrolling along the endothelium ( Figure 4E , lower graph), whereas phosphate-buffered saline ( Figure 4E , upper graph) and native LDL (data not shown) did not.
We next characterized the patrolling behavior of NCM that had ingested OxLDL. Within 10 minutes post-injection, CX 3 CR1
high NCM had taken up DiI-OxLDL, which localized to the rear cell body and not in the leading edge of the lamellipodia ( Figure 4F and Movie I in the online-only Data Supplement). At no point did we observe extravasation of the monocytes into the surrounding leg muscle tissue in mice fed either chow or WD. However, we did notice slingshot-like behavior of CX 3 CR1
high NCM that rapidly attached to the endothelium and immediately transitioned into patrolling (Movie II in the online-only Data Supplement). These results suggest that oxidized lipoprotein moieties present in the vasculature during early atherogenesis bind to SRs on NCM and induce an activation cascade that triggers NCM patrolling. gfp/+ ApoE −/− mice were imaged to obtain a baseline of patrolling frequency in a large blood vessel of a mouse leg (left column). Phosphate-buffered saline (PBS; 100 μL) or OxLDL (100 μg) solutions were injected during imaging after obtaining a baseline. Time-lapse images were obtained post-injection from the same preinjected areas (right column). White arrows highlight patrolling NCM. Quantification of patrolling frequency before and after injection of PBS (upper graph) or OxLDL (lower graph) were graphed for each condition. n=3 independent experiments, 1 representative experiment shown. Scale bar=30 μM. F, Representative figure of CX 3 CR1 gfp/+ ApoE −/− mice injected with DiI-OxLDL during imaging to observe OxLDL uptake by NCM while patrolling. n=2 independent experiments. Scale bar=30 μM. gMFI indicates geometric mean fluorescence intensity. Error bars represent mean±SEM for all graphs. *P<0.05, **P<0.01, ***P<0.001. November 2017
NCM Lacking CD36 Fail to Patrol the Vasculature in Early Atherogenesis
CD36 and Msr1 (macrophage scavenger receptor 1; SR-A) are known SRs involved in the uptake of OxLDL. 10 Based on our data that illustrate that NCM preferentially uptake OxLDL and that this OxLDL uptake changes the F-actin content of NCM (Figure 3) , we examined monocyte patrolling in mice lacking either SR-A, Msr1, or the class B SR CD36, or both. Msr1 −/− , CD36 −/− , or Msr1 −/− CD36 −/− doubleknockout (DKO) mice were fed a WD for 28 days before imaging. Circulating NCM in these mice were labeled with CD115-AF488 and FcγRIV(CD16.2)-PE 34 for imaging. We found that monocytes from WD-fed CD36 −/− or DKO mice showed significantly reduced patrolling in response to WD, and in some of the CD36 −/− or DKO mice, patrolling was completely abolished ( Figure 5A ). Fewer CD36 −/− NCM patrolled the endothelium ( Figure 5B ) although the numbers of NCM present in blood were similar in WT than in CD36 −/− mice ( Figure 5C ). Of the NCM that did patrol in the CD36 −/− and Msr1 −/− or DKO mice, mean speeds of patrolling were significantly reduced ( Figure 5D ). Interestingly, the patrolling characteristics of the NCM were different in the Msr1 −/− mice ( Figure VA in the online-only Data Supplement), such that they uniformly patrolled slower and To determine whether CD36 expression on the NCM rather than on the vascular endothelium was critical in directing patrolling behavior, we performed a bone marrow transplant where we transplanted WT bone marrow into either WT or CD36 −/− recipients. We found that patrolling behavior was similar in WT and CD36 −/− recipients, confirming that deletion of CD36 −/− on the endothelium plays an insignificant role in directing NCM patrolling ( Figure 5F and Figure VD in the online-only Data Supplement). Additionally, we tested NCM from TLR7 −/− or CX 3 CR1 −/− mice for patrolling activity based on our previous reports that illustrated that these receptors played functional roles in NCM. 3, 35 Neither receptor played a role in orchestrating the patrolling behavior of NCM in response to WD feeding ( Figure VE in the online-only Data Supplement).
Human CD16 + NCM also possess SRs capable of binding and internalizing OxLDL, including CD163 (SR class I), SR-A (CD204), and to a lesser extent CD36 ( Figure VIA in the online-only Data Supplement). They also possess high levels of tetraspanin CD81 ( Figure VIA in the online-only Data Supplement), which has been shown to associate with CD36 and assists in internalizing the receptor upon binding to OxLDL. 18 Although expression is much higher in mouse NCM, transcript and protein levels of CD36 in human NCM are detectable by qPCR ( Figure VIB in the online-only Data Supplement) and flow cytometry ( Figure 5G ). Moreover, when whole blood from healthy donors was incubated with various forms of LDL, similar to the in vivo injections in mouse, OxLDL was preferentially taken up by CD16 + monocytes ( Figure 5H ).
Ly6C − Monocytes Utilize SFKs and DAP12 to Patrol During Early Atherosclerosis
CD36 lacks a cytoplasmic tail that can propagate signaling cascades on its own and must rely on adapter proteins. 18 We examined the effect of deleting DAP12, a known CD36-associated adapter protein, on NCM patrolling in WD-fed mice. We transplanted DAP12 −/− bone marrow into WT recipients, let mice recover and then fed the mice WD for 28 days. After WD feeding, we observed a significant 2-fold reduction in the number of NCM patrolling the vasculature ( Figure 6A) . Moreover, the mean speed of NCM patrolling along the vasculature was higher in the absence of DAP12 ( Figure 6B ), suggesting that the NCM lacking DAP12 could not adequately respond to the presence of OxLDL in vivo. There was no significant difference in the frequency of NCM in blood of DAP12 −/− mice ( Figure VIIA in the online-only Data Supplement).
Next, we examined which kinases might be acting downstream of CD36. We inhibited phosphorylation of Syk and SFK, 2 kinases known to transduce signals between receptors and integrins, We injected either PP1 (pyrazolopyrimidine, Src family tyrosine kinase inhibitor), a reversible cell permeable SFK inhibitor, or Piceatannol, a cell permeable Syk phosphorylation inhibitor, intravenously into WD-fed CX 3 CR1 gfp/+ CCR2 rfp/+ ApoE −/− mice and imaged NCM patrolling ( Figure 6C ). Within 20 minutes of injection, NCM that had been actively patrolling either arrested or detached from the endothelium ( Figure 6C ). When vehicle (equal amount DMSO diluted with phosphate-buffered saline) was injected by the same route, patrolling monocytes continued to crawl along the vasculature undisturbed ( Figure 6C ). In contrast, injection of Piceatannol had no effect on patrolling ( Figure 6C and Figure VIIB in the online-only Data Supplement).
We next performed immunoblotting for active site phosphorylation of SFKs in NCM from chow or WD-fed WT or CD36 −/− mice or from WT WD-fed mice treated with PP1. We used the pan-pSFK Y416 antibody, which recognizes SFK phosphorylation at the Y416 active site. NCM from WD-fed mice showed activation of SFKs as measured by Y416 phosphorylation ( Figure 6D ). Phosphorylation was abrogated with addition of the PP1 inhibitor ( Figure 6D ). Importantly, NCM from CD36 −/− mice showed no activated pSFK ( Figure 6D ), supporting the notion that ligand binding of CD36 requires downstream activation of SFKs to induce patrolling. Thus, NCM require CD36-ligand binding and signaling through DAP12 to activate SFKs for inducing patrolling along blood vessel walls in WD-fed mice.
Discussion
In this study, we examine how NCM patrolling behavior is changed in early atherogenesis. We found that patrolling by NCM is significantly increased in the vasculature during early atherogenesis, and that patrolling in this setting was triggered by SR recognition and uptake of OxLDL, primarily through CD36, and to a lesser extent, SR-A. This signal is transmitted through DAP12 and SFKs, culminating in changes in F-actin formation in NCM, leading to patrolling along the vascular endothelium. Our data suggest that SFK and DAP12 are working downstream of CD36 to promote integrin activation and dynamic changes in F-actin that lead to patrolling.
We also examined patrolling activity of NCM in Msr1 −/− mice. We did not observe a significant difference in patrolling frequency in the global Msr1 −/− mice, nor did we detect a significant change in OxLDL uptake by Msr1 −/− NCM. It is possible that changes in the patrolling characteristics of NCM in Msr1 −/− mice may be contributed by the endothelium. In the Msr1 −/− CD36 −/− DKO bone marrow transfer experiment that we performed, CD36 behaved as the dominant receptor on NCM, as the patrolling frequency and characteristics of these monocytes looked similar to CD36 −/− mice. We further examined CD36 −/− recipient mice that had been transplanted with WT bone marrow to explore how selective endothelial loss of CD36 would impact patrolling. We found no changes in patrolling behavior in the absence of endothelial CD36, suggesting that endothelial CD36 had little impact on regulation of NCM patrolling in WD-fed mice. Further, we examined the role of DAP12, a CD36-adaptor protein, and found that the absence of DAP12 in NCM significantly reduced, but did not completely abolish, patrolling. Thus, other pathways, in addition to CD36, likely play a role in regulating NCM patrolling in response to WD-feeding during early atherogenesis.
Previous studies 3, 36 have shown that LFA-1 (lymphocyte function-associated antigen) and VLA-4 (very late antigen) integrins mediate patrolling, particularly in atherosclerotic mice. It has been proposed that Gαi chemokine receptors are necessary for inducing patrolling in NCM during inflammation. 35 However, we did not observe significant reductions in NCM patrolling after pertussis toxin injections of WD-fed mice. We propose that integrin changes in affinity conformation are responsible for the increase in patrolling, and that this is because of CD36 activation in response to OxLDL sensing in early atherogenesis. Because of the lack of integrin conformation-specific antibodies available for mice and because the human patient with coronary artery disease samples used in our study were processed using EDTA (which prevents integrins from reaching high-affinity conformations), we could not directly link CD36 with integrin conformational changes. However, we have shown that F-actin formation, which is necessary for cell motility, is indeed increased in NCM from WD-fed mice, as well as when OxLDL is bound to NCM.
As a SR, CD36 can bind to multiple ligands, including OxLDL and apoptotic cells via recognition of oxidized phosphatidylserine and oxidized phospholipids. 37 Studies from our laboratory and others have shown than NCM scavenge apoptotic endothelial cells, and tumor debris in the vasculature. 35 Further, NCM can migrate to and enter sites of atherosclerotic plaque formation in mice. 4 Whether the trigger for NCM patrolling in early atherogenesis is OxLDL itself or some oxidized moiety present in the OxLDL that is a ligand for SRs is unclear. Thus, we cannot rule out that other ligands or other OxLDL moieties are binding to CD36 on NCM during atherosclerosis and triggering patrolling. It is clear that the absence of NCM increases plaque formation in mice, but the exact roles of CD36 on NCM as it pertains to atherosclerosis progression remains a question for future studies.
SFKs consist of several members shown to be involved in signal transduction that are present in monocytes including Src, Lyn, and Fyn. We found that NCM from WD-fed mice have higher levels of phosphorylated SFK at the activation site Y416 using a pan-SFK antibody. Further, in vivo administration of the SFK inhibitor PP1 abrogated patrolling. In support of this, we have observed that Csk, a negative regulator of SFK, is increased in NCM in WD-fed mice (Figure 2A) , further suggesting that SFKs are activated in NCM during WD-feeding. 38 Conversely, in vivo administration of Piceatannol (Syk inhibitor) failed to abolish patrolling in WD-fed mice, suggesting that Syk is not involved in regulation of CD36-mediated NCM patrolling in atherogenesis. We have not yet definitively determined which SFK contributes to CD36-mediated NCM patrolling.
In contrast to mouse monocytes, human CD14 dim CD16 + monocytes have low levels of CD36 expression compared with the classical subset. However, human CD14 dim CD16 + monocytes do express some low levels of CD36 and higher levels of the CD36-associated tetraspanin CD81. In addition, they possess relatively abundant levels of other SRs that are capable of taking up OxLDL, such as SR-A and CD163. We found that OxLDL is indeed preferentially taken up by human NCM, which may be bound by CD36 or one of the other more abundant SRs that can bind OxLDL. In summary, by using intravital imaging in vivo to examine NCM function in large peripheral blood vessels during early stages of atherosclerosis, we have discovered that NCM respond to OxLDL and show increased patrolling along the vascular endothelium. In mice, this seems to be mediated by CD36, and recognition of OxLDL by CD36 causes downstream activation of SFKs, which promote cytoskeletal changes, leading to increased patrolling. Further studies to dissect the role of CD36 in NCM activation during atherogenesis will enhance our understanding of how the innate immune system controls inflammation and atherosclerotic plaque formation.
